Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heplisav-B in healthcare worker hepatitis B vaccine nonresponders
NCT04456504Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by University of Wisconsin–Madison. Started Sep 2020; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04456504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04456504.